Sergey Zakharov Selected Research

Sergey Zakharov Research Topics

Disease

38	Poisoning 01/2023 - 08/2012
4	Inflammation (Inflammations) 01/2020 - 02/2016
3	Neuroinflammatory Diseases 01/2020 - 04/2017
3	Optic Nerve Diseases (Optic Neuropathy) 01/2019 - 01/2018
3	Acidosis 12/2018 - 12/2014
2	Alcoholism (Alcohol Abuse) 12/2022 - 01/2020
2	Neoplasms (Cancer) 12/2020 - 01/2020
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019 - 12/2018
2	Disease Progression 01/2017 - 02/2015
2	Coma (Comas) 05/2015 - 12/2014
2	Heart Failure 05/2013 - 02/2007
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Cognitive Dysfunction 10/2021
1	Necrosis 12/2020
1	Vision Disorders (Hemeralopia) 12/2020
1	Burns 07/2020
1	Ganglion Cysts (Ganglion) 01/2020
1	Polyneuropathies (Polyneuropathy) 01/2020
1	Memory Disorders (Memory Loss) 01/2019
1	Critical Illness (Critically Ill) 12/2018
1	Hypotension (Low Blood Pressure) 12/2018
1	Lactic Acidosis 12/2018
1	Cerebral Hemorrhage 11/2016
1	Hypoalbuminemia 01/2016
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2015
1	Occupational Asthma 04/2014
1	Myocardial Infarction 05/2013
1	Tics (Tic) 08/2012
1	Ischemia 02/2007
1	Hypertension (High Blood Pressure) 02/2007

Drug/Important Bio-Agent (IBA)

37	Methanol (Carbinol)IBA 01/2023 - 07/2014
11	Ethanol (Ethyl Alcohol)IBA 01/2020 - 12/2014
6	AntidotesIBA 01/2020 - 12/2014
5	Fomepizole (Antizol)FDA LinkGeneric 01/2020 - 12/2014
5	formic acid (formate)IBA 12/2018 - 07/2014
3	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2017
3	LeukotrienesIBA 01/2020 - 04/2017
2	CreatinineIBA 03/2021 - 01/2016
2	Lactic Acid (Lactate)FDA LinkGeneric 03/2021 - 12/2018
2	Retinaldehyde (Retinal)IBA 01/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	EnzymesIBA 01/2016 - 02/2015
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 07/2015 - 02/2015
1	FilaminsIBA 01/2023
1	Lysine Carboxypeptidase (Carboxypeptidase N)IBA 12/2022
1	inter-alpha-inhibitorIBA 12/2022
1	alpha-2-Antiplasmin (alpha 2 Antiplasmin)IBA 12/2022
1	Heparin (Liquaemin)FDA LinkGeneric 12/2022
1	PlasminogenIBA 12/2022
1	von Willebrand FactorIBA 12/2022
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 12/2022
1	ProteomeIBA 12/2022
1	Glucose (Dextrose)FDA LinkGeneric 03/2021
1	ioflupaneIBA 03/2021
1	Nicotine FDA Link 07/2020
1	Nucleic AcidsIBA 01/2020
1	Leukotriene B4IBA 01/2020
1	Leukotriene E4IBA 01/2020
1	LipidsIBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Leukotriene C4IBA 01/2020
1	Leukotriene D4IBA 01/2020
1	Apolipoprotein E4IBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 12/2018
1	Interleukin-10 (Interleukin 10)IBA 12/2018
1	InterleukinsIBA 12/2018
1	LipoxinsIBA 12/2018
1	lipoxin A4IBA 12/2018
1	Interleukin-13IBA 12/2018
1	lipoxin B4IBA 12/2018
1	Interleukin-9 (Interleukin 9)IBA 12/2018
1	Interleukin-5 (Interleukin 5)IBA 12/2018
1	Membrane LipidsIBA 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	AerosolsIBA 02/2016
1	ferric oxide (iron oxide)IBA 02/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2016
1	mancozebIBA 01/2016
1	ElectrolytesIBA 01/2016
1	sodium thiosulfate FDA Link 09/2015
1	Hydroxocobalamin FDA Link 09/2015
1	Cyanides (Isocyanides)IBA 09/2015
1	microsomal ethanol-oxidizing system (MEOS)IBA 02/2015
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2015
1	Dialysis SolutionsIBA 07/2014
1	AllergensIBA 04/2014
1	salicylhydroxamic acid (SHAM)IBA 05/2013
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 05/2013
1	beta Adrenergic ReceptorsIBA 02/2007
1	Insulin ReceptorIBA 02/2007
1	CationsIBA 02/2007

Therapy/Procedure

7	Renal Dialysis (Hemodialysis) 01/2020 - 07/2014
5	Continuous Renal Replacement Therapy 01/2020 - 07/2014
2	Treatment Delay 01/2017 - 01/2016
1	Subacute Care 01/2021
1	Hemodiafiltration 07/2014
1	Medication Errors (Medication Error) 08/2012